These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22786602)

  • 21. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
    Orton SM; Ramagopalan SV; Para AE; Lincoln MR; Handunnetthi L; Chao MJ; Morahan J; Morrison KM; Sadovnick AD; Ebers GC
    J Neurol Sci; 2011 Jun; 305(1-2):116-20. PubMed ID: 21440908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
    Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
    Paradela ER; Alves-Leon SV; Figueiredo AL; Pereira VC; Malfetano F; Mansur LF; Scherpenhuijzen S; Agostinho LA; Rocha CF; Rueda-Lopes F; Gasparetto E; Paiva CL
    Arq Neuropsiquiatr; 2015 Apr; 73(4):283-8. PubMed ID: 25992516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
    Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
    Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious mononucleosis-linked HLA class I single nucleotide polymorphism is associated with multiple sclerosis.
    Jafari N; Broer L; Hoppenbrouwers IA; van Duijn CM; Hintzen RQ
    Mult Scler; 2010 Nov; 16(11):1303-7. PubMed ID: 20736246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aetiology: Neighbourhood watch.
    Brown C
    Nature; 2016 Nov; 540(7631):S4-S6. PubMed ID: 27902678
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].
    Blaschek A; Huppke P; Kümpfel T; Müller-Felber W; Rostasy K
    Nervenarzt; 2017 Dec; 88(12):1377-1384. PubMed ID: 29038883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No evidence of IL21 association with multiple sclerosis in a Swedish population.
    Lindén M; Nohra R; Sundqvist E; Khademi M; Hillert J; Alfredsson L; Olsson T; Kockum I
    Tissue Antigens; 2011 Oct; 78(4):271-4. PubMed ID: 21736561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA Genetic Risk Burden in Multiple Sclerosis.
    Mühlau M; Andlauer TF; Hemmer B
    JAMA Neurol; 2016 Dec; 73(12):1500-1501. PubMed ID: 27775759
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA Genetic Risk Burden in Multiple Sclerosis-Reply.
    Isobe N; Oksenberg JR; Henry RG
    JAMA Neurol; 2016 Dec; 73(12):1501-1502. PubMed ID: 27775754
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
    Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
    Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability.
    Balnytė R; Rastenytė D; Ulozienė I; Mickevičienė D; Skordenienė E; Vitkauskienė A
    Medicina (Kaunas); 2011; 47(7):368-73. PubMed ID: 22112985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic predictors of relapse rate in pediatric MS.
    Graves JS; Barcellos LF; Shao X; Noble J; Mowry EM; Quach H; Belman A; Casper TC; Krupp LB; Waubant E;
    Mult Scler; 2016 Oct; 22(12):1528-1535. PubMed ID: 26769066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
    Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
    Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic background of multiple sclerosis.
    Sadovnick AD
    Autoimmun Rev; 2012 Jan; 11(3):163-6. PubMed ID: 21619948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.